Clinical Trials

Hematologic Neoplasms

NCT05968170 2025-07-14

TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant

Graft vs Host Disease, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04820894 2025-05-23

Perception of Cure Among Patients With Metastatic Cancer

Neoplasm Metastasis, Hematologic Neoplasms

NCT05600556 2025-05-15

Virtual Reality for the Improvement of Patients Understanding of Disease and Treatment (MRgRT)

Hematologic Neoplasms

NCT01660347 2025-05-02

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

Classical hematologyOther hematologic neoplasm

Anemia, Lymphopenia, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT04781855 2025-02-28

Ipilimumab, Ibrutinib, and Nivolumab for the Treatment of Chronic Lymphocytic Leukemia and Richter Transformation

Leukemia, Lymphocytic, Chronic, B-Cell, Hematologic Neoplasms

NCT06543511 2024-11-22

MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies

Hematologic Neoplasms

NCT05660421 2024-10-31

Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors

Hematologic Neoplasms

NCT05288595 2024-10-18

TCR Alpha/Beta and CD19-deplete Haplo-HSCT

Hematologic Neoplasms

NCT02298816 2024-10-03

HMvax-Regist

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Influenza, Human, Lymphocytosis, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Pneumonia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Hematologic Neoplasms

NCT04275154 2024-09-03

Immunological Parameters, Neurocognitive Changes, Activity, & Driving Fitness in Patients Undergoing CAR-T Cell Therapy

Hematologic Neoplasms

NCT04955938 2024-07-31

A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms

MyeloidOther hematologic neoplasm

Leukemia, Myeloproliferative Disorders, Hematologic Neoplasms

NCT05403580 2024-05-06

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer

Phase 3 Withdrawn

Hematologic Neoplasms

NCT03959046 2024-02-15

GIST in Hematopoietic Stem Cell Transplantation/Bone Marrow Transplantation

Neoplasms, Hematologic Neoplasms

NCT04684979 2023-11-01

Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malignancies

Lymphoma, Non-Hodgkin, Hematologic Neoplasms

NCT05205252 2023-08-15

ARIA

Classical hematologyOther hematologic neoplasm

Hematologic Neoplasms

NCT05061654 2023-08-14

CEF-10

Phase 4 Withdrawn

Hematologic Neoplasms, Febrile Neutropenia

NCT04190433 2023-05-24

Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial

BreastLymphoidOther hematologic neoplasmSarcoma

Breast Neoplasms, Lymphoma, Sarcoma, Hematologic Neoplasms

NCT03688789 2023-03-31

HemaSur

Hematologic Neoplasms

NCT05038384 2023-03-31

Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work

Hematologic Neoplasms

NCT01792882 2023-02-28

GBCPRT0008

BreastGastrointestinalGenitourinaryOther hematologic neoplasmThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT04282174 2022-09-27

2019-KOE-001

LymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04138875 2022-06-23

A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)

Infectious Mononucleosis, Hematologic Neoplasms

NCT04605614 2022-06-09

64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression

Phase EARLY_PHASE1 Withdrawn

Hematologic Neoplasms

NCT04803630 2022-05-12

Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM Study

Hematologic Neoplasms

NCT04331483 2022-02-28

EVAADE

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Myelodysplastic Syndromes, Severe Combined Immunodeficiency, Hematologic Neoplasms

NCT04464889 2021-10-08

HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT04390542 2021-07-20

Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy

Hematologic Neoplasms

NCT04455958 2021-04-26

Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year

Hematologic Neoplasms

NCT03739606 2020-12-17

Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer

LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Hodgkin Disease, Leukemia, Hairy Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms, Mastocytosis, Systemic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03804164 2020-12-17

Psycho-Educational Cognition Intervention in Patients With Blood and Lymph Cancer

Hematologic Neoplasms

NCT04127721 2020-10-29

Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation

Hematologic Diseases, Hematologic Neoplasms

NCT02487459 2020-10-05

Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02786485 2020-10-05

Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hematologic Diseases, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Hematologic Neoplasms

NCT04428918 2020-09-22

Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell Transplantation

Hematologic Neoplasms

NCT04392128 2020-09-04

HYACINTHE

COVID-19, Hematologic Neoplasms

NCT04439305 2020-07-20

Testing Dasatinib as a Potential Targeted Treatment in Cancers With DDR2 Genetic Changes (MATCH-Subprotocol X)

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT04016116 2020-05-27

Dual PD-1 and JAK2 Inhibition in Hematological Malignancies

Neoplasms, Hematologic Neoplasms

NCT03986086 2020-03-20

MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Hematologic Neoplasms

NCT02709993 2019-10-14

Consolidation Therapy in Patients With Hematologic Malignancies

Neoplasms, Hematologic Neoplasms

NCT02355431 2019-03-08

Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations

Other hematologic neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Hematologic Neoplasms

NCT01479582 2018-12-21

Providing Access to Cord Blood Units for Transplants

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Thalassemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Lysosomal Storage Diseases, Hematologic Neoplasms

NCT03531281 2018-12-07

Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Hematologic Neoplasms

NCT02223312 2018-08-28

Therapy for Progressive and/or Refractory Hematologic Malignancies

Neoplasms, Hematologic Neoplasms

NCT03086252 2018-07-26

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

Classical hematologyMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Anemia, Aplastic, Leukemia, Myelodysplastic Syndromes, Hematologic Neoplasms

NCT02718755 2018-06-26

Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies

Burkitt Lymphoma, Lymphoma, Recurrence, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01163201 2017-12-02

T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Lymphoma, Follicular, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02118311 2017-12-02

Treg Cells for AGVHD in Non-myeloablative UCB Transplant